Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1984 Jul 7;289(6436):3–4. doi: 10.1136/bmj.289.6436.3

Rifampicin in non-tuberculous infections.

A J Davies, D A Lewis
PMCID: PMC1442054  PMID: 6428654

Full text

PDF
3

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acocella G., Brumfitt W., Hamilton-Miller J. M. Evidence that rifampicin can be used safely for non-tuberculous diseases. Thorax. 1980 Oct;35(10):788–791. doi: 10.1136/thx.35.10.788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Amler R. W., Orenstein W. A., Bart K. J. Aerosolized measles vaccine--will it open the window? Rev Infect Dis. 1983 May-Jun;5(3):524–526. doi: 10.1093/clinids/5.3.524. [DOI] [PubMed] [Google Scholar]
  3. Archer G. L., Tenenbaum M. J., Haywood H. B., 3rd Rifampin therapy of Staphylococcus epidermidis. Use in infections from indwelling artificial devices. JAMA. 1978 Aug 25;240(8):751–753. [PubMed] [Google Scholar]
  4. Cox F., Trincher R., Rissing J. P., Patton M., McCracken G. H., Jr, Granoff D. M. Rifampin prophylaxis for contacts of Haemophilus influenzae type b disease. JAMA. 1981 Mar 13;245(10):1043–1045. [PubMed] [Google Scholar]
  5. Darougar S., Viswalingam N., El-Sheikh H., Hunter P. A., Yearsley P. A double-blind comparison of topical therapy of chlamydial ocular infection (TRIC infection) with rifampicin or chlortetracycline. Br J Ophthalmol. 1981 Aug;65(8):549–552. doi: 10.1136/bjo.65.8.549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Daum R. S., Glode M. P., Goldmann D. A., Halsey N., Ambrosino D., Welborn C., Mather F. J., Willard J. E., Sullivan B., Murray M. Rifampin chemoprophylaxis for household contacts of patients with invasive infections due to Haemophilus influenzae type b. J Pediatr. 1981 Mar;98(3):485–491. doi: 10.1016/s0022-3476(81)80731-7. [DOI] [PubMed] [Google Scholar]
  7. Eickhoff T. C. Letter: Meningococcal prophylaxis. JAMA. 1975 Oct 13;234(2):150–151. doi: 10.1001/jama.234.2.150. [DOI] [PubMed] [Google Scholar]
  8. Emmerson A. M., Grüneberg R. N., Johnson E. S. The pharmacokinetics in man of a combination of rifampicin and trimethoprim. J Antimicrob Chemother. 1978 Nov;4(6):523–531. doi: 10.1093/jac/4.6.523. [DOI] [PubMed] [Google Scholar]
  9. Giamarellou H., Kosmidis J., Leonidas M., Papadakis M., Daikos G. K. A study of the effectiveness of rifaprim in chronic prostatitis caused mainly by Staphylococcus aureus. J Urol. 1982 Aug;128(2):321–324. doi: 10.1016/s0022-5347(17)52906-7. [DOI] [PubMed] [Google Scholar]
  10. Glode M. P., Daum R. S., Goldmann D. A., Leclair J., Smith A. Haemophilus influenzae type B meningitis: a contagious disease of children. Br Med J. 1980 Mar 29;280(6218):899–901. doi: 10.1136/bmj.280.6218.899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Harvey K., Pavillard R. Methicillin resistance in Staphylococcus aureus with particular reference to Victorian strains. Med J Aust. 1982 May 29;1(11):465–467. [PubMed] [Google Scholar]
  12. Jariwalla A. G., Davies B. H., White J. Infective endocarditis complicating psittacosis: response to rifampicin. Br Med J. 1980 Jan 19;280(6208):155–155. doi: 10.1136/bmj.280.6208.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kerry D. W., Hamilton-Miller J. M., Brumfitt W. Trimethoprim and rifampicin: in vitro activities separately and in combination. J Antimicrob Chemother. 1975 Dec;1(4):417–427. doi: 10.1093/jac/1.4.417. [DOI] [PubMed] [Google Scholar]
  14. Lorber B. Rifampin in chronic granulomatous disease. N Engl J Med. 1980 Jul 10;303(2):111–111. doi: 10.1056/NEJM198007103030217. [DOI] [PubMed] [Google Scholar]
  15. McAllister W. A., Thompson P. J., Al-Habet S. M., Rogers H. J. Rifampicin reduces effectiveness and bioavailability of prednisolone. Br Med J (Clin Res Ed) 1983 Mar 19;286(6369):923–925. doi: 10.1136/bmj.286.6369.923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McDougal L. K., Thornsberry C. In-vitro bactericidal synergism of rifampicin and trimethoprim and implications for treatment of carriers of Haemophilus influenzae. J Antimicrob Chemother. 1982 May;9(5):369–378. doi: 10.1093/jac/9.5.369. [DOI] [PubMed] [Google Scholar]
  17. Murphy T. V., McCracken G. H., Jr, Zweighaft T. C., Hansen E. J. Emergence of rifampin-resistant Haemophilus influenzae after prophylaxis. J Pediatr. 1981 Sep;99(3):406–409. doi: 10.1016/s0022-3476(81)80328-9. [DOI] [PubMed] [Google Scholar]
  18. Sande M. A., Scheld W. M. Combination antibiotic therapy of bacterial endocarditis. Ann Intern Med. 1980 Mar;92(3):390–395. doi: 10.7326/0003-4819-92-3-390. [DOI] [PubMed] [Google Scholar]
  19. Swartz M. N. Clinical aspects of Legionnaires' disease. Ann Intern Med. 1979 Apr;90(4):492–495. doi: 10.7326/0003-4819-90-4-492. [DOI] [PubMed] [Google Scholar]
  20. Weidmer C. E., Dunkel T. B., Pettyjohn F. S., Smith C. D., Leibovitz A. Effectiveness of rifampin in eradicating the meningococcal carrier state in a relatively closed population: emergence of resistant strains. J Infect Dis. 1971 Aug;124(2):172–178. doi: 10.1093/infdis/124.2.172. [DOI] [PubMed] [Google Scholar]
  21. Zinner S. H., Lagast H., Klastersky J. Antistaphylococcal activity of rifampin with other antibiotics. J Infect Dis. 1981 Oct;144(4):365–371. doi: 10.1093/infdis/144.4.365. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES